VANCOUVER, December 1, 2021 - The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response.
Read More
CHÉOS Scientist Dr. Brian Grunau says results from the first peer-reviewed study in North America on COVID-19 mRNA vaccines could inform vaccination policies
Read More
This edition includes disease burden among the world's poorest people, resuscitation methods in pediatric OHCA, and quality of life of living kidney donors after surgery
Read More
Results from an innovative CHÉOS-led clinical trial show the sedative is effective, and could be safer for patients and staff
Read More
New research from the CHÉOS Emergency Medicine Program shows that paramedic encounters decreased by 15 per cent in the first three months of the pandemic
Read More
CHÉOS Scientists are leading three of the projects funded through this round of the competition and a further seven projects are supported by CHÉOS Scientists as co-investigators
Read More
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
Read More
CHÉOS Scientist Dr. Brian Grunau is PI of this study, which will also determine how many paramedics have had COVID-19 and will investigate how long antibodies last
Read More
Paramedics are the focus of a new COVID-19 study, led by CHÉOS Scientist Dr. Brian Grunau
Read More
This edition includes treatment of out-of-hospital cardiac arrest, implementation of mifepristone medical abortion, and non-traditional factors that contribute to type 2 diabetes
Read More